From the archives: Lady Davis Institute opens at the JGH in 1969
In 1969, the Lady Davis Institute opened at the JGH and went on to become one of Quebec’s leading facilities for medical research.
From the archives: Dr. Mark Wainberg, HIV/AIDS pioneer, opens ultra-secure JGH lab
Testing and research into HIV/AIDS took a major step forward in June 2007 with the inauguration of a $5 million HIV/AIDS Bio-containment Laboratory whose development was spearheaded by research pioneer Dr. Mark Wainberg.
Appointments and congratulations
The JGH Centre for Child Development and Mental Health has a new Director of Child Psychiatry, Dr. Paola Habib.
Neurofeedback may prove useful only for its placebo effects
Although there is little scientific evidence that behaviour can be changed with the help of neurofeedback, some benefits may still result from the technique’s placebo effects.
Men have a lot to learn about their own fertility
Canadian men—regardless of their age, education or income level—generally lack knowledge about the risk factors that contribute to male infertility, the first large-scale study of its kind has revealed.
Study confirms need for further integrated care and support for thyroid cancer patients
A two-year study at the JGH has determined that thyroid cancer patients really need and benefit from the support of a nurse navigator.
Mandate renewed for Canada-wide drug safety consortium based at the LDI
A renewed five-year mandate has been granted to a national consortium on prescription drug safety that is headquartered in the Lady Davis Institute at the JGH.
In memoriam
Members of the JGH family mourn the loss on July 14 of Herbert E. Siblin, who served as President of the Board of Directors from 1983 to 1985.
Broader screening helps reduce C. difficile infection
The rate of C. difficile infection among hospitalized patients drops dramatically when all patients are tested for the bacteria before being admitted to hospital, says a clinical study headed by a JGH physician and researcher.
Key mechanism identified in deadly brain tumours
A key to understanding the formation of the most aggressive type of brain tumour in adults has been revealed at the JGH.